Genomatix Wins BioChance Grant for $1.6 Mio Research Project into RNAi Mediated Regulatory Networks
Genomatix Software GmbH has won a "BioChance" research contract from the German Federal Ministry of education and Research to pursue research in RNAi mediated regulatory networks and to further expand its competence and product line into this exciting new field. The project is scheduled to run for two years and is worth more than US$ 1.6 million.
Genomatix own unique competence in the biology of gene regulation will be complemented by at least two academic research partners (the LMU Munich and the DKFZ Heidelberg) who will carry out the wet lab experimental part of the research.
Organizations
Other news from the department business & finance

Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents

A muscle protein promotes nerve healing
Roche: Phase III study evaluating ocrelizumab in patients with rheumatoid arthritis meets primary endpoint
Medical_cannabis
Category:Biological_matter
Anergis obtains U.S. patent for AllerT
Synthon enters into global license agreement with Amgen and Watson for biosimilar trastuzumab
Nematophagous_fungus

Major findings help understand bacteria's 'superglue' - Understanding these superglue proteins could help in the battle against antibiotic resistance
Motor_unit_recruitment
Category:Carboxamides
